Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents

BACKGROUND: Protein tyrosine phosphatase (PTP) 1B, a negative regulator of the insulin and leptin signaling pathways, is currently considered a promising target for the development of novel therapeutic approaches used to treat insulin-resistant type 2 diabetes mellitus (IR-T2DM). In this study, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoda, Toshihisa, Li, Wei, Higai, Koji, Koike, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936919/
https://www.ncbi.nlm.nih.gov/pubmed/24555682
http://dx.doi.org/10.1186/1472-6882-14-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936919/
https://www.ncbi.nlm.nih.gov/pubmed/24555682
http://dx.doi.org/10.1186/1472-6882-14-64

Ejemplares similares